Jerome Lozada

417 total citations
16 papers, 356 citations indexed

About

Jerome Lozada is a scholar working on Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Jerome Lozada has authored 16 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Organic Chemistry and 7 papers in Molecular Biology. Recurrent topics in Jerome Lozada's work include Medical Imaging Techniques and Applications (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Click Chemistry and Applications (4 papers). Jerome Lozada is often cited by papers focused on Medical Imaging Techniques and Applications (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Click Chemistry and Applications (4 papers). Jerome Lozada collaborates with scholars based in Canada, Türkiye and Russia. Jerome Lozada's co-authors include David M. Perrin, Zhibo Liu, Zhibo Liu, Kuo‐Shyan Lin, Paul Schaffer, May Q. Wong, Donald T. Yapp, Ying Li, Michael J. Adam and Thomas J. Ruth and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Jerome Lozada

15 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerome Lozada Canada 9 165 151 113 74 69 16 356
Ulrike Voigtmann Germany 11 228 1.4× 194 1.3× 213 1.9× 71 1.0× 95 1.4× 12 501
Romain Béjot United States 13 209 1.3× 161 1.1× 114 1.0× 110 1.5× 41 0.6× 25 422
Aurélie Maisonial‐Besset France 16 266 1.6× 117 0.8× 237 2.1× 33 0.4× 84 1.2× 33 538
Lutz F. Schweiger United Kingdom 12 75 0.5× 173 1.1× 111 1.0× 70 0.9× 77 1.1× 21 436
Aileen Höhne Germany 6 74 0.4× 221 1.5× 100 0.9× 82 1.1× 111 1.6× 6 342
Mohammad B. Haskali Australia 12 78 0.5× 201 1.3× 106 0.9× 86 1.2× 104 1.5× 39 380
Oleksiy Itsenko Sweden 11 121 0.7× 165 1.1× 69 0.6× 135 1.8× 24 0.3× 19 345
Gemma Dias United Kingdom 11 51 0.3× 194 1.3× 116 1.0× 35 0.5× 147 2.1× 21 347
Joseph Arukwe Norway 8 109 0.7× 237 1.6× 116 1.0× 47 0.6× 106 1.5× 16 357
Sue Champion United Kingdom 7 89 0.5× 116 0.8× 69 0.6× 80 1.1× 41 0.6× 12 237

Countries citing papers authored by Jerome Lozada

Since Specialization
Citations

This map shows the geographic impact of Jerome Lozada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Lozada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Lozada more than expected).

Fields of papers citing papers by Jerome Lozada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome Lozada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Lozada. The network helps show where Jerome Lozada may publish in the future.

Co-authorship network of co-authors of Jerome Lozada

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome Lozada. A scholar is included among the top collaborators of Jerome Lozada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome Lozada. Jerome Lozada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Liu, Kun, Nicole Robinson, Jerome Lozada, et al.. (2025). Baited SELEX: Drug-Directed Selection of Aptamers to PSMA for In Vivo Targeting of Prostate Cancer Xenografts in Mice. Journal of the American Chemical Society. 147(44). 40879–40894. 1 indexed citations
2.
Lozada, Jerome, et al.. (2025). Synthesis and Preclinical Evaluation of Dual-Mode Fluorescent 18F-PET Tracers Targeting PSMA. Journal of Medicinal Chemistry. 68(15). 16645–16665. 1 indexed citations
3.
Blanc, Antoine, Jerome Lozada, Jutta Zeisler, et al.. (2024). 5‐Hydroxypyrroloindoline Affords Tryptathionine and 2,2′‐bis‐Indole Peptide Staples: Application to Melanotan‐II. Chemistry - A European Journal. 30(19). 3 indexed citations
4.
Lozada, Jerome, et al.. (2023). Salt Metathesis: Tetrafluoroborate Anion Rapidly Fluoridates Organoboronic Acids to give Organotrifluoroborates. Angewandte Chemie International Edition. 62(16). e202215371–e202215371. 15 indexed citations
6.
Lozada, Jerome, et al.. (2023). Imidazolium‐methylene‐trifluoroborate: A novel radioprosthetic group validated with preclinical 18F‐Positron Emission Tomography imaging of Prostate Specific Membrane Antigen in mice. Journal of Labelled Compounds and Radiopharmaceuticals. 66(4-6). 130–137. 1 indexed citations
7.
Eltit, Felipe, Nicole Robinson, Mitali Pandey, et al.. (2023). The “Ins and Outs” of Prostate Specific Membrane Antigen (PSMA) as Specific Target in Prostate Cancer Therapy. Advances in experimental medicine and biology. 1408. 291–308. 1 indexed citations
8.
Kwon, Daniel, Jerome Lozada, Zhengxing Zhang, et al.. (2020). High-Contrast CXCR4-Targeted 18F-PET Imaging Using a Potent and Selective Antagonist. Molecular Pharmaceutics. 18(1). 187–197. 25 indexed citations
9.
Lozada, Jerome, Mathieu L. Lepage, Chengcheng Zhang, et al.. (2020). Synthesis and 18F-radiolabeling of thymidine AMBF3 conjugates. RSC Medicinal Chemistry. 11(5). 569–576. 3 indexed citations
10.
Lozada, Jerome, Zhibo Liu, & David M. Perrin. (2014). Base-Promoted Protodeboronation of 2,6-Disubstituted Arylboronic Acids. The Journal of Organic Chemistry. 79(11). 5365–5368. 96 indexed citations
11.
Liu, Zhibo, Ying Li, Jerome Lozada, et al.. (2013). Stoichiometric Leverage: Rapid 18F‐Aryltrifluoroborate Radiosynthesis at High Specific Activity for Click Conjugation. Angewandte Chemie International Edition. 52(8). 2303–2307. 60 indexed citations
12.
Liu, Zhibo, Ying Li, Jerome Lozada, et al.. (2013). Stoichiometric Leverage: Rapid 18F‐Aryltrifluoroborate Radiosynthesis at High Specific Activity for Click Conjugation. Angewandte Chemie. 125(8). 2359–2363. 10 indexed citations
13.
Li, Ying, Zhibo Liu, Jerome Lozada, et al.. (2013). Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice. Nuclear Medicine and Biology. 40(8). 959–966. 30 indexed citations
14.
Chua, Peter, Geoffrey C. Winters, Jerome Lozada, et al.. (2013). Selective radiosensitization of hypoxic cells using BCCA621C: a novel hypoxia activated prodrug targeting DNA-dependent protein kinase. 1. 20 indexed citations
15.
Liu, Zhibo, Ying Li, Jerome Lozada, et al.. (2013). Kit-like 18F-labeling of RGD-19F-Arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging. Nuclear Medicine and Biology. 40(6). 841–849. 52 indexed citations
16.
Liu, Zhibo, Ying Li, Jerome Lozada, et al.. (2012). Rapid, one‐step, high yielding 18F‐labeling of an aryltrifluoroborate bioconjugate by isotope exchange at very high specific activity. Journal of Labelled Compounds and Radiopharmaceuticals. 55(14). 491–496. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026